ImClone Systems Inc. said yesterday that its Erbitux colon-cancer treatment, which may reach patients as soon as tomorrow, will cost about $10,000 a month.
ImClone and a partner, the Bristol-Myers Squibb Company, will begin shipping Erbitux today, after winning regulatory approval on Feb. 12.
Erbitux will cost $2,400 a dose.
